Assembly Biosciences (ASMB) Prepaid Assets (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Prepaid Assets of $5.6 million for Q1 2026, up 23.61% year-over-year from $4.5 million in Q1 2025, and up 1.68% quarter-over-quarter from $5.5 million in Q4 2025.
Analysis
Assembly Biosciences (ASMB) Prepaid Assets (2010 - 2026) Analysis & Trends
Assembly Biosciences' Prepaid Assets history runs 17 years deep, the most recent figure standing at $5.6 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 23.61% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (up 23.61% YoY), while the FY2025 annual figure was $5.5 million, up 59.73% from the prior year.
- Prepaid Assets for Q1 2026 stood at $5.6 million, up from $5.5 million in the prior quarter.
- The five-year high for Prepaid Assets was $7.3 million in Q1 2022, with the low at $2.5 million in Q2 2025.
- The 5-year median for Prepaid Assets is $4.1 million (2024), against an average of $4.5 million.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets tumbled 44.82% in 2023, then soared 59.73% in 2025.
- Assembly Biosciences' Prepaid Assets stood at $4.4 million in 2022, then dropped by 20.76% to $3.5 million in 2023, then dropped by 2.09% to $3.4 million in 2024, then jumped by 59.73% to $5.5 million in 2025, then climbed by 1.68% to $5.6 million in 2026.
- Business Quant data shows ASMB's Prepaid Assets at $5.6 million in Q1 2026, $5.5 million in Q4 2025, and $3.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Assembly Biosciences | 689.29 Mn | 368.93 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.80 Mn |
| Mar 31, 2026 | 5.56 Mn |
| Dec 31, 2025 | 5.47 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 2.49 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 3.42 Mn |
| Sep 30, 2024 | 3.26 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Mar 31, 2024 | 4.15 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Sep 30, 2023 | 3.46 Mn |
| Jun 30, 2023 | 3.91 Mn |
| Mar 31, 2023 | 6.01 Mn |
| Dec 31, 2022 | 4.41 Mn |
| Sep 30, 2022 | 5.18 Mn |
| Jun 30, 2022 | 7.08 Mn |
| Mar 31, 2022 | 7.25 Mn |
| Dec 31, 2021 | 7.24 Mn |
| Sep 30, 2021 | 6.55 Mn |